Mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en Oriente Medio y África: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en Oriente Medio y África

Los ensayos multiplex son una nueva tecnología que incorpora la capacidad de ejecutar más de una secuencia objetivo en un solo paso, la evolución de los ensayos multiplex de reacción en cadena de la polimerasa (PCR) en términos de funciones inteligentes con comando de voz, autenticación facial y características de identificación por radiofrecuencia (RFID) cambia de un instrumento manual a un sistema de multiplex de PCR automatizado. Los principales factores que se espera que impulsen el crecimiento del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en el período de pronóstico son las ventajas de rango que ofrecen los ensayos multiplex de reacción en cadena de la polimerasa (PCR), como múltiples secuencias en una sola reacción que son rentables, precisas, confiables y rápidas. Además, se anticipa que el creciente gasto para mejorar la infraestructura de atención médica impulsará aún más el crecimiento del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR). Por otro lado, se proyecta que la falta de profesionales capacitados o experiencia capacitada impedirá aún más el crecimiento del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en el período de tiempo. Sin embargo, la naturaleza complicada de los instrumentos de ensayos multiplex de reacción en cadena de la polimerasa (PCR) podría desafiar aún más el crecimiento del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en breve.

El segmento de productos y servicios está dominando el mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) debido a la creciente incidencia de enfermedades crónicas y al crecimiento de la población.

Data Bridge Market Research analiza que el mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) se valoró en USD 773,55 millones en 2022 y se estima que alcanzará los USD 1.042,47 millones para 2030, y se espera que crezca a una CAGR del 3,80% durante el período de pronóstico de 2023 a 2030. El informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis profundo de expertos, epidemiología de los pacientes, análisis de la cartera de productos, análisis de precios y marco regulatorio. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado curados por Data Bridge Market Research incluyen un análisis profundo de expertos, epidemiología de los pacientes, análisis de la cartera de productos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en Oriente Medio y África

Market Definition

Polymerase chain reaction (PCR) multiplex assays are advanced molecular diagnostic tools that enable the simultaneous amplification and detection of multiple DNA or RNA targets in a single reaction. These assays are extensively employed in various applications, such as infectious disease diagnostics, genetic testing, forensics, and research. Additionally, PCR multiplex assays are invaluable tools for research purposes. They enable scientists to study the expression of multiple genes or detect the presence of specific genetic sequences simultaneously. This is particularly useful in fields such as cancer research, where the analysis of multiple genetic markers can provide insights into disease progression, prognosis, and therapeutic response.

Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Dynamics

Drivers

• Increasing Prevalence of Infectious Diseases

The Middle East and Africa region witness a significant burden of infectious disease, including respiratory infections, gastrointestinal infections, sexually transmitted diseases, and vector-borne diseases. The growing prevalence of these diseases drives the demand for PCR multiplex assays, as they offer rapid and accurate detection of multiple pathogens, aiding in effective disease management and control.

• Rising Adoption of Personalized Medicine

Increasing trend toward personalized medicine in the Middle East and Africa region. PCR multiplex assays play a crucial role in personalized medicine by enabling the detection of genetic variations associated with drug response, disease susceptibility, and treatment efficacy. The growing demand for customized medicine drives the adoption of PCR multiplex assays in the region.

• Advancements in Molecular Diagnostics

Technological advancements in PCR techniques and molecular diagnostics have enhanced the performance and efficiency of PCR multiplex assays. The development of advanced PCR platforms, novel reagents, and improved assay design has facilitated the simultaneous detection of multiple targets with higher sensitivity and specificity. These advancements drive the adoption of PCR multiplex assays in the Middle East and Africa.

Opportunity

• Increasing Focus on Precision Medicine

Precision medicine, which aims to tailor medical treatments to individual patients based on their genetic characteristics, is gaining traction in the Middle East and Africa region. PCR multiplex assays offer a powerful tool for genetic profiling and identification of genetic markers associated with specific diseases. The growing focus on precision medicine presents a significant opportunity for the expansion of the PCR multiplex assays market.

• Growing Demand for Point-of-Care Testing

There is an increasing demand for rapid and accurate diagnostic tests at the point of care in the Middle East and Africa region. PCR multiplex assays, with their ability to detect multiple targets in a single reaction, can be utilized as point-of-care tests for infectious diseases, genetic testing, and other applications. The rising demand for point-of-care testing creates opportunities for the PCR multiplex assays market.

Restraint

• High Cost of PCR Multiplex Assays

The cost associated with PCR multiplex assays, including equipment, reagents, and maintenance, can significantly restrain market growth in the Middle East and Africa region. Limited healthcare budgets and affordability may hinder the widespread adoption of PCR multiplex assays, particularly in resource-constrained settings, leading to slower market growth.

Challenge

• Limited Infrastructure and Skilled Workforce

The Middle East and Africa region faces challenges in terms of limited infrastructure and a shortage of skilled professionals in the field of molecular diagnostics. They are establishing and maintaining the necessary laboratory infrastructure. Establishing and maintaining the required laboratory infrastructure can be a time-consuming and costly. It involves acquiring PCR instruments, thermocyclers, centrifuges, and other essential laboratory equipment. Additionally, a reliable power supply and access to quality reagents and consumables are crucial for conducting PCR multiplex assays. Inadequate infrastructure can limit the capacity to perform these assays efficiently and may lead to delays in diagnosis or unreliable test results.

This Middle East and Africa polymerase chain reaction (PCR) multiplex assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa polymerase chain reaction (PCR) multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In October 2021, Bio-Rad Laboratories launched the Reliance One-Step Multiplex Supermix, a PCR multiplex assay designed to rapidly and accurately detect respiratory pathogens. This product launch by Bio-Rad Laboratories in 2021 is a significant development in the PCR multiplex assays market
• In July 2021, Bioneer Corporation partnered with Seegene Inc. to develop a multiplex PCR assay to detect COVID-19 variants and other respiratory pathogens. The partnership between Bioneer Corporation and Seegene Inc. aims to develop a multiplex PCR assay for detecting COVID-19 variants and other respiratory pathogens.
• In August 2020, Luminex Corporation acquired MilliporeSigma's flow cytometry and multiplex assay product portfolio, expanding its offerings in multiplex PCR assays and other molecular diagnostic technologies. This strategic move allowed Luminex to expand its offerings in multiplex assays and strengthen its position in the molecular diagnostics market

Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Scope

The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market is segmented based on products & services, applications, and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Product & Services

• Reagents and consumables
• Instruments and accessories
• Software and services

Application

• Research and development
• Clinical diagnostics

End User

• Pharmaceutical and biotechnology companies
• Research institutes
• Hospitals
• Clinical laboratories others

Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Regional Analysis/Insights

The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market is analyzed, and market size insights and trends are provided by country, type, and end-user, as referenced above.

The countries covered in the Middle East and Africa polymerase chain reaction (PCR) multiplex assays market report are the Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

Saudi Arabia is expected to dominate and witness significant growth in the market due to growing applications of polymerase chain reaction (PCR) multiplex assays in research and development.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future market trends. Data points like downstream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Polymerase Chain Reaction (PCR) Multiplex Assays Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Market. The data is available for historic period 2015-2020.

Competitive Landscape and Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Share Analysis

El panorama competitivo del mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) de Oriente Medio y África proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia en Oriente Medio y África, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la extensión de los productos, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas relacionado con el mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) de Oriente Medio y África.

Algunos de los principales actores que operan en el mercado de ensayos multiplex de reacción en cadena de la polimerasa (PCR) en Oriente Medio y África son:

• Hologic Inc. (Estados Unidos)
• Luminex Corporation, una empresa de DiaSorin (EE. UU.)
• BD. (Estados Unidos)
• Abbott. (Estados Unidos)
• Thermo Fisher Scientific Inc. (Estados Unidos)
• QIAGEN (Alemania)
• Agilent Technologies Inc. (Estados Unidos)
• MESO SCALE DIAGNOSTICS, LLC (EE. UU.)
• Randox Laboratories Ltd. (Reino Unido)
• Bio-Techne (Estados Unidos)
• Seegene Inc. (Corea del Sur)
• Olink (Suecia)
• Illumina, Inc. (Estados Unidos)
• Laboratorios Bio-Rad, Inc. (Estados Unidos)
• Abcam plc (Reino Unido)
• Quanterix (Estados Unidos)
• Corporación Sysmex (Japón)
• Siemens (Alemania)
• DiaSorin SpA (Italia)
• Quest Diagnostics Incorporated (Estados Unidos)
• PerkinElmer Inc. (Estados Unidos)
• Eurofins Scientific (Luxemburgo)
• Agena Bioscience, Inc. (Estados Unidos)
• F. Hoffmann-La Roche Ltd (Suiza)

SKU-41257